What to expect in the Kailera Therapeutics, Inc. interview process

Based on information found online, Kailera Therapeutics is a heavily funded biotechnology research company founded in 2024 and headquartered in Waltham, Massachusetts, with an additional footprint in San Diego, California. Operating with a team of roughly 101 to 200 employees (specifically noted at 139), the company is led by biopharma veterans, including President and CEO Ron Renaud, who previously guided Cerevel Therapeutics and Translate Bio through major acquisitions.

The company's workplace environment blends hub-based requirements with remote flexibility depending on the role. For instance, positions like the Senior Specialist in GMP Quality Assurance require an on-site presence in Waltham, Massachusetts for 3 to 4 days per week, while remote roles such as Field Medical Affairs Medical Science Liaisons show average base salaries ranging between $196k and $235k.

Publicly available job postings outline a strong entrepreneurial and team-oriented culture focused on advancing clinical-stage injectable and oral obesity therapies, such as their lead dual agonist program, KAI-9531. Operational roles—like the Manager of Patient Retention and Senior Scientists supporting drug product formulation and manufacturing with external CDMO partners—emphasize a fast-paced environment geared toward data integrity, clinical trial execution, and cross-functional collaboration.